Company Name BioBehavioral Diagnostics
Mailing Address 239 Littleton Road Westford, MA 01886
Company Description BioBehavioral Diagnostics Company (BioBDx) is a privately held company whose mission is to develop, manufacture, and market proprietary diagnostic systems for the quantitative assessment of behavioral disorders, including the measurement of medication response and the prediction of therapeutic efficacy for a patient. The company’s lead product, the McLean Motion and Attention Test for Attention Deficit Hyperactivity Disorder (MMAT/ADHD™ System), is designed to enable clinicians to accurately make office based diagnoses for ADHD, select the right class of medication, and measure therapeutic efficacy of a given drug while determining an optimal dosage. The BioBDx product portfolio includes ADHD diagnostic aid systems for children, adolescents, and adults. The MMAT/ADHD™ System is currently FDA approved as an aid for the diagnosis of ADHD.